search
Back to results

Troponin T in Chronic Obstructive Pulmonary Disease (COPD) Patients After Physical Exercise

Primary Purpose

COPD, Myocardial Diseases

Status
Completed
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
Treadmill exercise test
Sponsored by
LHL Helse
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for COPD focused on measuring Troponin, Exercise

Eligibility Criteria

40 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • COPD
  • GOLD 2-4
  • BODE-index ≥ 2
  • Referred by physician to a CPET

Exclusion Criteria:

  • Other serious pulmonary diseases (e.g. cancer, sarcoidosis, restrictive pulmonary diseases)
  • Chronic heart disease with unstable angina or myocardial infarction ≤ 3 months prior to inclusion
  • Percutaneous coronary intervention (PCI)
  • Hypertension that is not controlled

Sites / Locations

  • LHL-klinikkene

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Treadmill exercise test

Arm Description

Patients are subjected to an incremental Cardiopulmonary Exercise Test to exhaustion

Outcomes

Primary Outcome Measures

Troponin T concentration 3 h

Secondary Outcome Measures

Full Information

First Posted
March 23, 2016
Last Updated
October 10, 2016
Sponsor
LHL Helse
search

1. Study Identification

Unique Protocol Identification Number
NCT02721693
Brief Title
Troponin T in Chronic Obstructive Pulmonary Disease (COPD) Patients After Physical Exercise
Official Title
COPD, Physical Exercise and Troponin T
Study Type
Interventional

2. Study Status

Record Verification Date
October 2016
Overall Recruitment Status
Completed
Study Start Date
April 2016 (undefined)
Primary Completion Date
October 2016 (Actual)
Study Completion Date
October 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
LHL Helse

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The primary purpose of the study is to investigate if physical exercise is associated with myocardial damage, expressed by elevated troponin T, in patients with COPD.
Detailed Description
Patients with COPD will perform a cardiopulmonary exercise test (CPET) on treadmill until exhaustion, 8-12 minutes. Venous blood will be drawn before exercise test and 15 minutes, 3 hours and 24 hours after test for analysis of high sensitive Cardiac troponin T (hs-cTnT). The investigators will also measure arterial bloodgas, oxygen uptake, carbon dioxide consumption, ventilation, blood pressure, ECG, heart rate and ask for dyspnea-score.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
COPD, Myocardial Diseases
Keywords
Troponin, Exercise

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
20 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Treadmill exercise test
Arm Type
Experimental
Arm Description
Patients are subjected to an incremental Cardiopulmonary Exercise Test to exhaustion
Intervention Type
Device
Intervention Name(s)
Treadmill exercise test
Intervention Description
Patients are subjected to an incremental exercise test to exhaustion on a treadmill
Primary Outcome Measure Information:
Title
Troponin T concentration 3 h
Time Frame
3 h

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: COPD GOLD 2-4 BODE-index ≥ 2 Referred by physician to a CPET Exclusion Criteria: Other serious pulmonary diseases (e.g. cancer, sarcoidosis, restrictive pulmonary diseases) Chronic heart disease with unstable angina or myocardial infarction ≤ 3 months prior to inclusion Percutaneous coronary intervention (PCI) Hypertension that is not controlled
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anne H Edvardsen, PhD
Organizational Affiliation
LHL Helse
Official's Role
Principal Investigator
Facility Information:
Facility Name
LHL-klinikkene
City
Hakadal
State/Province
Akershus
ZIP/Postal Code
1485
Country
Norway

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Troponin T in Chronic Obstructive Pulmonary Disease (COPD) Patients After Physical Exercise

We'll reach out to this number within 24 hrs